Related Experiment Video

Updated: Jul 16, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

[Experimental basis for the treatment of drug-resistant epilepsy]

Barbara Błaszczyk1, Marcin Trojnar, Stanisław J Czuczwar

  • 1Oddział Neurologii, Wojewódzki Zespół Opieki Neuropsychiatrycznej, Kielce.

Przeglad Lekarski
|March 14, 2007
PubMed

Insights

Selecting antiepileptic drug combinations for drug-resistant epilepsy requires careful consideration of preclinical seizure and neurotoxicity data. Some combinations show synergistic anticonvulsant effects with non-synergistic neurotoxicity, potentially improving treatment outcomes.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epileptology

Context:

  • Drug-resistant epilepsy (DRE) presents significant treatment challenges.
  • Pathophysiology of DRE involves blood-brain barrier transporters, receptor/channel alterations, and neurodegeneration.
  • Current treatment often relies on combined antiepileptic drug (AED) therapies.

Purpose:

  • To evaluate AED combinations for DRE based on preclinical seizure and neurotoxicity data.
  • To identify AED combinations with synergistic anticonvulsant effects and non-synergistic neurotoxicity.
  • To guide the selection of effective and safe AED combinations for DRE.

Summary:

  • AED combinations like topiramate + lamotrigine, topiramate + oxcarbazepine, and valproate + lamotrigine demonstrate synergy in seizure tests and antagonism/additivity in neurotoxicity tests.
  • Levetiracetam + carbamazepine (or oxcarbazepine) or topiramate, and tiagabine + gabapentin show anticonvulsant synergy with neurotoxic additivity.
  • Lamotrigine + carbamazepine (or oxcarbazepine) exhibits antagonism in seizure tests, contrasting with its frequent clinical application.

Impact:

  • Preclinical seizure and neurotoxicity data can optimize AED combination selection for DRE.
  • This approach may lead to improved therapeutic strategies for patients with DRE.
  • Understanding combination effects is crucial, particularly for frequently used but potentially antagonistic combinations like lamotrigine + carbamazepine.

More Related Videos

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...